|
|
  
Pulse Check:
Trends in Drug Abuse
November 2001
Appendix 5: Discussion Areas by Source Type*
|
Topic
|
L
|
E
|
M
|
N
|
| SNAPSHOT |
| How serious
is the current illegal drug problem in your community? |
 |
 |
 |
 |
| How has the
illegal drug problem changed in your community? |
 |
 |
 |
 |
| THE
PERCEPTION |
|
|
|
|
What is the
most commonly abused drug in your community during the current
reporting period?
Second most commonly abused drug? What drug is related to the
most serious consequences?
Second most serious consequences? Is any new problem drug appearing
in your community? |
 |
 |
 |
 |
What was
the most commonly abused drug in you community during the last
reporting period?
Second most commonly abused drug in your community? What drug
was related to the most serious consequences last reporting period?
Second most serious consequences? |
 |
 |
 |
 |
| THE
DRUG** |
| How available
is the drug in your community (for each drug, asks about various
forms)? |
 |
 |
|
|
| How has availability
changed? |
 |
 |
|
|
| What are
the most common and second most common units of sale and corresponding
standard units of the drug? |
 |
 |
|
|
| What is the
purity range for the drug during the current reporting period?
During the last reporting period? |
 |
 |
|
|
| What is the
price range during the current reporting period? During the last
reporting period? |
 |
 |
|
|
| What is the
source for your price and purity information? |
 |
 |
|
|
| Why have
price and purity changed or why have they remained stable? |
 |
 |
|
|
| What are
the street names, and are any of these new this reporting period? |
 |
 |
 |
 |
| What types
of packaging are used, and are any of these new this reporting
period? |
 |
 |
|
|
| Are labels
or brand names used? If yes, please list and indicate if any are
new this reporting period. |
 |
 |
|
|
| Are there
any adulterants? If yes, please list and indicate if any are new
this reporting period. |
 |
 |
 |
 |
| Have there
been any changes in street names, packaging, labels, or adulterants
since the last reporting period? If yes, please describe. |
 |
 |
|
|
| THE
SALE** |
| How is the
drug manufactured, processed, or grown? |
 |
 |
|
|
| What is the
source country or point of origin? |
 |
 |
|
|
| What are
the transshipment cities? |
 |
 |
|
|
| What is the
point of entry? |
 |
 |
|
|
| What is the
final destination city or region? |
 |
 |
|
|
| Have there
been any changes in manufacturing process or trafficking since
the last reporting period? If yes, please describe. |
 |
 |
|
|
| What is the
predominant affiliation of local, street-level sellers? |
 |
 |
|
|
| How likely
are sellers to use their own drugs? |
 |
 |
|
|
| How involved
in other crimes are sellers? |
 |
 |
|
|
| In what type
of other crimes are sellers involved? |
 |
 |
|
|
| Have there
been any changes in seller characteristics since the last reporting
period? If yes, please describe. |
 |
 |
|
|
| Are there
any new sellers groups this reporting period? If yes, please describe. |
 |
 |
|
|
| What is the
geographical area where most street-level sales of the drug occur? |
 |
 |
|
|
| Is the drug
sold mostly indoors, outdoors, or evenly split between both? |
 |
 |
|
|
| In what settings
is the drug sold? |
 |
 |
|
|
| How is the
drug sold? |
 |
 |
|
|
| Are other
drugs sold by this type of dealer? If yes, please list the drugs. |
 |
 |
|
|
| Have any
of the drugs sold with this drug changed since the last reporting
period? If yes, please describe. |
 |
 |
|
|
| What are
any other distinctive features of the drug scene in your area? |
 |
 |
|
|
| Have any
of the drug scene characteristics changed since the last reporting
period? If yes, please describe. |
 |
 |
|
|
THE USERS: Predominant characteristics**
|
L |
E |
M |
N |
| What is the
predominant age range of the drug users? |
|
 |
 |
 |
| What is the
predominant gender? |
|
 |
 |
 |
| What is the
predominant racial/ethnic group? Is this group underrepresented,
overrepresented, or about equal compared with the general population
in your area? |
|
 |
 |
 |
| What is the
predominant socioeconomic position? |
|
 |
 |
 |
| What is the
most common geographical residence? |
|
 |
 |
 |
| What is the
predominant route of administration? |
|
 |
 |
 |
What are
the drugs commonly taken in combination with this drug, including
any street names for the combination or practice?
Is the drug used mostly indoors or outdoors? |
|
 |
 |
 |
| Is the drug
used mostly in public or in private? |
|
 |
 |
 |
| Is the drug
used mostly alone or in groups/among friends? |
|
 |
 |
 |
| What are
the common settings for the use of this drug? |
|
 |
 |
 |
| What are
the unusual settings or contexts for the use of this drug? |
|
 |
 |
 |
| What is the
most common referral source? |
|
|
 |
 |
| What is the
predominant education level? |
|
|
 |
 |
| What is the
most common frequency of use? |
|
|
 |
 |
| What is the
predominant employment status? |
|
|
 |
 |
| THE
USERS: New or emerging users** |
| How did the
number of new or emerging users change since the last reporting
period? If increased, repeat the first 12 questions under "the
users: predominant characteristics" for the new/emerging user
group. |
|
 |
|
|
| How did the
number of novice users in your program change since the last reporting
period? If increased, repeat all questions under "the users: predominant
characteristics" for the novice user group. |
|
|
 |
 |
| METHADONE
DIVERSION/TREATMENT |
| To what extent
is there a methadone diversion problem from treatment programs
in your community? |
 |
|
|
|
| How has the
diversion problem changed since the last reporting period? |
 |
|
|
|
| Is illegal
methadone transported into your community from other areas? |
 |
|
|
|
| Who has been
selling diverted methadone? |
 |
|
|
|
| How is it
sold? |
 |
|
|
|
| Who has been
buying diverted methadone? |
 |
|
|
|
| What is the
availability of methadone treatment in your community? |
|
 |
|
|
| How has treatment
availability changed since the last reporting period? |
|
 |
|
|
| What is the
capacity of public methadone treatment? Private methadone treatment? |
|
 |
|
|
| How has the
capacity of public methadone treatment changed since the last
reporting period? Private methadone treatment? |
|
 |
|
|
| COMMUNITY
CONTEXTS |
| Were there
substantial changes or issues involving (treatment availability
or waiting time, drug-related hospital medical emergencies, drug-related
deaths, large drug seizures, targeted law enforcement policy directives
or initiatives, community policing, new sentencing practices,
new joint task forces, new legislation, new community education
or prevention programs, new public service campaigns, drug-related
news events, other)? If yes, please describe. |
 |
 |
|
|
| How did medical,
political, criminal, or societal changes or issues (listed above)
impact your community''s overall drug abuse problem? |
 |
 |
|
|
| Have drug-related
consequences (HIV/AIDS, hepatitis C, liver cirrhosis, drug-related
automobile accidents, high-risk pregnancy, drug overdoses, alcohol
DTs, tuberculosis, other) increased, decreased, or remained stable
since the last reporting period? If changed, explain. |
|
|
 |
 |
| Have any
of the psychiatric comorbidity diagnoses (conduct disorder, psychosis,
mood disorders, suicidal thoughts/attempts, other) increased,
decreased, or remained stable as a concern among your clients
since last reporting period? If changed, explain. |
|
|
 |
 |
| Do any potential
barriers (limited slot capacity, lack of trained staff to treat
comorbid clients, violent behavior among presenting clients, age
restrictions, other) prevent your program from serving all individuals
who seek treatment? If yes, explain. |
|
|
 |
 |
| Have any
factors (law enforcement referral patterns, waiting lists, treatment
funding slot capacity, access to treatment at other local programs,
program outreach, media attention, availability, purity, overdoses
just prior to treatment, withdrawal just prior to treatment, adulterants,
route of administration, other drugs used concurrently, other
drugs used by clients, other) contributed to increases or decreases
in your program''s number of admissions related to any specific
drug? If yes, describe. |
|
|
 |
 |
| Have any
legal issues (nonviolent offenses, violent offenses, gang-related
activity, prostitution, drug-assisted rape, domestic violence,
DUI/DWI, other) increased or decreased as concerns among your
clients since the last reporting period? If yes, describe. |
|
|
 |
 |
| TREATMENT
BACKGROUND |
| What is your
program’s maximum capacity? |
|
|
 |
 |
| What is your
current enrollment? |
|
|
 |
 |
| Does your
program’s clientele reflect the population of your local community?
If no, please describe. |
|
|
 |
 |
| SPECIAL
TOPIC: SYNTHETIC OPIOIDS |
|
|
|
|
| All the above
topics in "the drug," "the sale," and "the users: predominant
characteristics" section were discussed about diverted/abused
synthetic opioids (specify). In addition, the following topics
were discussed: |
 |
 |
 |
 |
| How serious
is the problem in your community? |
 |
 |
 |
 |
| How has the
problem in your community changed since the last reporting period? |
 |
 |
|
|
| What are
the sources of illicit distribution of the drug? |
 |
 |
|
|
| Are there
a substantial number of impaired health care professionals using
the drug in your community? If yes, explain. |
|
 |
 |
 |
| Is the drug
continually on the illicit drug market or does it emerge periodically? |
 |
 |
|
|
| Is there
prevalence for opioid-naive adolescents in your community? If
yes, explain. |
|
 |
|
|
| Are highly
tolerant or experienced opioid abusers using? If yes, explain. |
|
 |
 |
 |
| Is the drug
used to replace heroin, used with heroin, or is its use not associated
with heroin use? |
|
 |
 |
 |
| Is the user
population in your community new this reporting period? |
|
 |
 |
 |
| In your opinion,
has the media overemphasized, underplayed, or reflected accurately
the problem in your community? |
 |
 |
 |
 |
| Have there
been any related health consequences, comorbidity/dual diagnoses,
barriers to treatment, or legal issues related to the drug’s abuse? |
|
|
 |
 |
LLaw enforcement
EEpidemiologic/ethnographic
MMethadone treatment
NNon-methadone treatment
*Please note that for the methadone and non-methadone treatment interviews,
"community" was replaced with "program."
**Respondents were asked about heroin, crack cocaine, powder cocaine,
methamphetamine, marijuana, ecstasy, GHB, ketamine, Rohypnol, hallucinogens
(specify), and any other drugs (specify) for each of the discussion
areas.
|